Literature DB >> 7766954

The discovery of phenylketonuria.

I Følling1.   

Abstract

In 1934, two severely mentally retarded children were examined by Dr Asbjørn Følling. He proved, by classical organic chemistry, that they excreted phenylpyruvic acid in their urine. The substance was also found in the urine of eight additional mentally retarded patients. Based on these observations, oligophrenia phenylpyrouvica (later termed phenylketonuria) was described as a new inborn error of metabolism. Følling later showed the pattern of an autosomal recessive genetic disease, probably caused by a block in phenylalanine metabolism, and that asymptomatic heterozygote carriers of the trait could be detected by phenylalanine loading. The stepwise elucidation and the line of reasoning are described. Phenylketonuria was the first inborn error of metabolism shown to affect the mind, and its importance as a model disease is emphasized. The article finally gives some insight into aspects of the personality of the discoverer.

Entities:  

Mesh:

Year:  1994        PMID: 7766954     DOI: 10.1111/j.1651-2227.1994.tb13440.x

Source DB:  PubMed          Journal:  Acta Paediatr Suppl        ISSN: 0803-5326


  12 in total

1.  Public and private academic medical partnerships in improving nutritional management in phenylketonuria.

Authors:  V Lewis; S Krause; C Myers
Journal:  Am J Public Health       Date:  1997-08       Impact factor: 9.308

Review 2.  Inborn errors of metabolism in the 21st century: past to present.

Authors:  Georgianne L Arnold
Journal:  Ann Transl Med       Date:  2018-12

Review 3.  Garrod's foresight; our hindsight.

Authors:  C R Scriver
Journal:  J Inherit Metab Dis       Date:  2001-04       Impact factor: 4.982

4.  Phenylketonuria: an inborn error of phenylalanine metabolism.

Authors:  Robin A Williams; Cyril D S Mamotte; John R Burnett
Journal:  Clin Biochem Rev       Date:  2008-02

Review 5.  Gene Therapy for the Treatment of Neurological Disorders: Metabolic Disorders.

Authors:  Dominic J Gessler; Guangping Gao
Journal:  Methods Mol Biol       Date:  2016

6.  Executive dysfunction in treated phenylketonuric patients.

Authors:  Bahare Azadi; Arshia Seddigh; Mehdi Tehrani-Doost; Javad Alaghband-Rad; Mahmoud Reza Ashrafi
Journal:  Eur Child Adolesc Psychiatry       Date:  2009-02-16       Impact factor: 4.785

Review 7.  Metabolic dysregulation in monogenic disorders and cancer - finding method in madness.

Authors:  Ayelet Erez; Ralph J DeBerardinis
Journal:  Nat Rev Cancer       Date:  2015-06-18       Impact factor: 69.800

Review 8.  Metabolic etiologies in West syndrome.

Authors:  Seda Salar; Solomon L Moshé; Aristea S Galanopoulou
Journal:  Epilepsia Open       Date:  2018-03-14

Review 9.  The Prevalence of Phenylketonuria in Arab Countries, Turkey, and Iran: A Systematic Review.

Authors:  Ashraf El-Metwally; Lujane Yousef Al-Ahaidib; Alaa Ayman Sunqurah; Khaled Al-Surimi; Mowafa Househ; Ali Alshehri; Omar B Da'ar; Hira Abdul Razzak; Ali Nasser AlOdaib
Journal:  Biomed Res Int       Date:  2018-04-18       Impact factor: 3.411

10.  Detection of novel visible-light region absorbance peaks in the urine after alkalization in patients with alkaptonuria.

Authors:  Yasunori Tokuhara; Kenichi Shukuya; Masami Tanaka; Mariko Mouri; Ryunosuke Ohkawa; Midori Fujishiro; Tomoo Takahashi; Shigeo Okubo; Hiromitsu Yokota; Makoto Kurano; Hitoshi Ikeda; Seiji Yamaguchi; Shinobu Inagaki; Mika Ishige-Wada; Hiromi Usui; Yutaka Yatomi; Tatsuo Shimosawa
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.